10% Owner Mark Strome Buys $200K in Zivo Bioscience Stock at Premium

summarizeSummary

A 10% owner of Zivo Bioscience, Mark E. Strome, purchased $200,000 worth of company stock in an open market transaction at a price significantly above the current market value.

check_boxKey Events

• Significant Insider Purchase

  Mark E. Strome, a 10% owner, acquired 100,000 shares of Zivo Bioscience common stock for a total of $200,000 in an open market purchase on April 17, 2026.

• Purchase at Premium to Market

  The shares were acquired at $2.00 per share, which is a significant premium compared to the current stock price of $1.20, indicating strong confidence from the reporting owner.

• Increased Ownership Stake

  Following this transaction, Strome Mark E's indirect holdings in Zivo Bioscience, Inc. increased to 572,942 shares.

auto_awesomeAnalysis

Mark E. Strome, a 10% owner of Zivo Bioscience, made a significant open market purchase of $200,000 in company stock. This transaction is particularly notable as the shares were acquired at $2.00 each, which is a substantial premium to the current stock price of $1.20. Such a purchase by a major shareholder, especially at a higher price than the prevailing market, signals strong conviction in the company's future prospects and adds to the recent pattern of insider accumulation.